Results 21 to 30 of about 3,631,955 (312)

Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study [PDF]

Frontiers in Immunology
This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies.
Luciana del Campo Guerola, Luciana del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Teresa Guerra-Galán, Eduardo de la Fuente-Munoz, Eduardo de la Fuente-Munoz, María Palacios-Ortega, María Palacios-Ortega, Miguel Fernández-Arquero, Miguel Fernández-Arquero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, Ascensión Peña-Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita-Mandly, Eduardo Anguita-Mandly, Teresa Benítez Jiménez, Celina Benavente Cuesta, Celina Benavente Cuesta, Silvia Sánchez-Ramón, Silvia Sánchez-Ramón   +24 more
doaj   +2 more sources

Cancer as secondary immunodeficiency. Review

Revista Alergia México, 2016
The secondary immunodeficiency’s, previously presented in immunocompetent individuals. The lack of primary or secondary response to the presence of a foreign antigen, in the case of infections is a sentinel data in the diagnosis of immunodeficiency (can ...
María Eugenia Vargas-Camaño, Ricardo Leopoldo Guido-Bayardo, Nora Ernestina Martínez-Aguilar, María Isabel Castrejón-Vázquez   +3 more
doaj   +3 more sources

A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants

Expert Review of Clinical Immunology, 2020
Introduction Secondary immunodeficiency diseases (SID) caused by hematological malignancies (HMs), stem cell transplant (SCT), and associated therapies are mainly characterized by the presence of hypogammaglobulinemia or antibody production deficits ...
C. Monleón Bonet, N. Waser, Karen O. Cheng, S. Tzivelekis, J. D. Edgar, S. Sánchez-Ramón   +5 more
semanticscholar   +3 more sources

Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. [PDF]

Front Immunol, 2019
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes.
Sánchez-Ramón S, Bermúdez A, González-Granado LI, Rodríguez-Gallego C, Sastre A, Soler-Palacín P, ID-Signal Onco-Haematology Group.   +6 more
europepmc   +2 more sources

MicroRNA Deregulation and Immune Checkpoint Interactions in Common Variable Immunodeficiency and CLL-Associated Secondary Immunodeficiency [PDF]

Cells
Background: Immunodeficiencies are a heterogeneous group of disorders classified etiologically as primary (congenital) or secondary (acquired). Primary immunodeficiencies (PIDs), such as common variable immunodeficiency (CVID), result from genetic ...
Paulina Mertowska, Sebastian Mertowski, Milena Czosnek, Barbara Sosnowska-Pasiarska, Aleksandra Krasińska-Płachta, Zbigniew Krasiński, Tomasz Urbanowicz, Krzysztof Bojarski, Mansur Rahnama-Hezavah, Ewelina Grywalska   +9 more
doaj   +2 more sources

Cost–utility analysis comparing hospital‐based intravenous immunoglobulin with home‐based subcutaneous immunoglobulin in patients with secondary immunodeficiency

Vox Sanguinis, 2019
Immunoglobulin replacement therapy (IRT) is often used to support patients with primary immunodeficiency disease (PID) and secondary immunodeficiency disease (SID).
T. Windegger, S. Nghiem, K. Nguyen, Y. Fung, P. Scuffham   +4 more
semanticscholar   +3 more sources

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha, B Gathmann, B Gathmann, B Piqueras, B Seymour, C Casulo, C Wehr, DF Florescu, E Becerra, E Castigli, ES Resnick, FA Bonilla, G Gunther, H Chapel, H Chapel, H Griffiths, Hilary J. Longhurst, HM Chapel, I De La Torre, I Quinti, J Blore, J Shortt, JA Freeman, JD Edgar, John Dempster, JS Orange, JS Orange, K Warnatz, K Warnatz, L Mouthon, Lorena Lorenzo, M Lucas, M Makatsori, M Yomota, Matthaios Speletas, Matthew Buckland, ME Conley, ME Rose, MJ Boumans, N Ozaras, N Venhoff, NH Yip, P Bright, P McLaughlin, P Wood, R Herriot, S Baris, S Bernatsky, S Molica, Sai S. Duraisingham, Sofia Grigoriadou, SS Duraisingham, T Kawano, U Salzer, W Al-Herz, W Strober   +55 more
core   +11 more sources

Secondary immunodeficiencies, including HIV infection [PDF]

Journal of Allergy and Clinical Immunology, 2010
Extrinsic factors can adversely affect immune responses, producing states of secondary immunodeficiency and consequent increased risk of infections. These immunodeficiencies, which can be encountered in routine clinical practice, arise from a number of conditions, such as treatment with glucocorticoids and immunomodulatory drugs, surgery and trauma ...
Javier, Chinen, William T, Shearer
  +7 more sources

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab

Hematology, 2022
Objectives: Chemotherapy, including bendamustine, usually causes lymphocytopaenia and hypogammaglobulinaemia as side effects in patients with haematological malignancies.
Akie Hirata, Kaname Miyashita, Takafumi Tanaka, Kiyoko Hirata, Taisuke Narazaki, Hayato Utsunomiya, Hirofumi Ohno, Eriko Nakashima, Yoshimichi Tachikawa, Ilseung Choi, Kenichi Taguchi, Youko Suehiro   +11 more
doaj   +1 more source

Interstitial Lung Disease in Immunocompromised Children

Diagnostics, 2022
Background: The range of pulmonary complications beyond infections in pediatric immunocompromised patients is broad but not well characterized. Our goal was to assess the spectrum of disorders with a focus on interstitial lung diseases (ILD) in ...
Xianfei Gao, Katarzyna Michel, Matthias Griese   +2 more
doaj   +1 more source